ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Stock Information for ABVC BioPharma Inc.
Loading
Please wait while we load your information from QuoteMedia.